Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

27.90
Delayed Data
As of Jul 21
 -0.60 / -2.11%
Today’s Change
7.65
Today|||52-Week Range
29.55
+130.58%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close28.50
Today’s open28.80
Day’s range27.50 - 28.80
Volume250,746
Average volume (3 months)360,125
Market cap$802.8M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+12.75%
Earnings growth (this year)+16.49%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+30.11%
P/E ratioNM
Price/Sales4.37
Price/Book6.99

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc-0.13-0.54%
ANIKAnika Therapeutics I...-1.04-2.12%
LMNXLuminex Corp-0.18-0.86%
MZORMazor Robotics Ltd-0.17-0.43%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateSeptember 6, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$78.7M
Annual profit (last year)-$25.2M
Net profit margin-32.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts